The MTF Biologics Allograft Research Award from Osteo Science Foundation funds innovative research advancing allograft tissue transplantation and regenerative medicine in Oral and CranioMaxillofacial Surgery.
Funder: Osteo Science Foundation
Due Dates (Anticipated): December 2026 (Full application deadline, projected; annual Oct 1–Dec 1 cycle)
Funding Amounts: $25,000 for one year; inclusive of indirect costs (max 10% overhead); one award per institution per cycle
Summary: Supports innovative research advancing allograft tissue transplantation and regenerative medicine, with focus on clinical translation in Oral and CranioMaxillofacial Surgery.
Key Information: An Oral and Maxillofacial Surgeon must be affiliated and contribute at least 10% effort; work must be conducted in the US or Canada.
This award, a collaboration between Osteo Science Foundation and MTF Biologics, funds research projects that advance the science of allograft tissue transplantation—especially those utilizing bone allograft in particulate or fiber form. The program emphasizes projects with strong clinical translation potential and the development of innovative techniques, materials, or technologies relevant to allograft-derived tissues. Areas of interest include combining allografts with biomaterials or biologics, novel uses of allograft-derived extracellular matrices, exosome exploration, and applications of precision medicine and AI for patient-matched therapies. The intent is to foster scientific progress in tissue engineering and regenerative medicine within Oral and CranioMaxillofacial Surgery.